RBC Capital analyst Shagun Singh raised the firm’s price target on Abbott to $128 from $119 and keeps an Outperform rating on the shares. The firm thinks Abbott is comfortable with current street estimates for 2024, and RBC sees room for upside given underlying momentum, execution, and innovation, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ABT:
- Abbott price target raised to $135 from $128 at BTIG
- Abbott Increases Quarterly Dividend for 52nd Consecutive Year
- Abbott boosts quarterly dividend 8% to 55c per share
- MDT, ABT: 2 Healthcare Dividend Aristocrat Stocks Hedge Funds are Bullish On
- Citi entering 2024 ‘cautiously optimistic’ on U.S. MedTech companies
